Parecoxib mitigates spatial memory impairment induced by sevoflurane anesthesia in aged rats

Acta Anaesthesiologica Scandinavica

Volumn 56, Issue 5, 2012, Pages 601-607

  Gong, M ^a   Chen, G ^a   Zhang, X M ^b   Xu, L H ^b   Wang, H M ^a   Yan, M ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; PARECOXIB; SEVOFLURANE;

AGED; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; FLOW RATE; HIPPOCAMPUS; LATENT PERIOD; LEARNING; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RAT; SPATIAL MEMORY; SYNAPSE; TASK PERFORMANCE;

AGING; ANESTHETICS, INTRAVENOUS; ANIMALS; BLOTTING, WESTERN; COGNITION DISORDERS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; HIPPOCAMPUS; ISOXAZOLES; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; METHYL ETHERS; MICROSCOPY, ELECTRON, TRANSMISSION; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES;

EID: 84862828538     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2012.02665.x     Document Type: Article

References (34)

1. Monk TG, Weldon BC, Garvan CW, Dede DE, van der, Aa MT, Heilman KM, Gravenstein JS,. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008; 108: 18-30.
2. Bitsch MS, Foss NB, Kristensen BB, Kehlet H,. Acute cognitive dysfunction after hip fracture: frequency and risk factors in an optimized, multimodal, rehabilitation program. Acta Anaesthesiol Scand 2006; 50: 428-436.
3. Evered L, Scott DA, Silbert B, Maruff P,. Postoperative cognitive dysfunction is independent of type of surgery and anesthetic. Anesth Analg 2011; 112: 1179-1185.
4. Carr ZJ, Torjman MC, Manu K, Dy G, Goldberg ME,. Spatial memory using active allothetic place avoidance in adult rats after isoflurane anesthesia: a potential model for postoperative cognitive dysfunction. J Neurosurg Anesthesiol 2011; 23: 138-145.
5. Peng S, Zhang Y, Sun DP, Zhang DX, Fang Q, Li GJ,. The effect of sevoflurane anesthesia on cognitive function and the expression of Insulin-like Growth Factor-1 in CA1 region of hippocampus in old rats. Mol Biol Rep 2011; 38: 1195-1199.
6. Culley DJ, Baxter MG, Crosby CA, Yukhananov R, Crosby G,. Impaired acquisition of spatial memory 2 weeks after isoflurane and isoflurane-nitrous oxide anesthesia in aged rats. Anesth Analg 2004; 99: 1393-1397.
7. Krenk L, Rasmussen LS, Kehlet H,. New insights into the pathophysiology of postoperative cognitive dysfunction. Acta Anaesthesiol Scand 2010; 54: 951-956.
8. Terrando N, Monaco C, Ma D, Foxwell BM, Feldmann M, Maze M,. Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci U S A 2010; 107: 20518-20522.
9. Yang H, Chen C,. Cyclooxygenase-2 in synaptic signaling. Curr Pharm Des 2008; 14: 1443-1451.
10. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF,. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993; 11: 371-386.
11. Andreasson KI, Savonenko A, Vidensky S, Goellner JJ, Zhang Y, Shaffer A, Kaufmann WE, Worley PF, Isakson P, Markowska AL,. Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J Neurosci 2001; 21: 8198-8209.
12. Jain NK, Patil CS, Kulkarni SK, Singh A,. Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide- induced cognitive dysfunction in mice. Behav Brain Res 2002; 133: 369-376.
13. Kotilinek LA, Westerman MA, Wang Q, Panizzon K, Lim GP, Simonyi A, Lesne S, Falinska A, Younkin LH, Younkin SG, Rowan M, Cleary J, Wallis RA, Sun GY, Cole G, Frautschy S, Anwyl R, Ashe KH,. Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain 2008; 131: 651-664.
14. Reksidler AB, Lima MM, Zanata SM, Machado HB, da, Cunha C, Andreatini R, Tufik S, Vital MA,. The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats. Eur J Pharmacol 2007; 560: 163-175.
15. Institoris A, Farkas E, Berczi S, Sule Z, Bari F,. Effects of cyclooxygenase (COX) inhibition on memory impairment and hippocampal damage in the early period of cerebral hypoperfusion in rats. Eur J Pharmacol 2007; 574: 29-38.
16. Xie Z, Culley DJ, Dong Y, Zhang G, Zhang B, Moir RD, Frosch MP, Crosby G, Tanzi RE,. The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid beta-protein level in vivo. Ann Neurol 2008; 64: 618-627.
17. Xie Z, Dong Y, Maeda U, Alfille P, Culley DJ, Crosby G, Tanzi RE,. The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology 2006; 104: 988-994.
18. Briones TL, Suh E, Jozsa L, Woods J,. Behaviorally induced synaptogenesis and dendritic growth in the hippocampal region following transient global cerebral ischemia are accompanied by improvement in spatial learning. Exp Neurol 2006; 198: 530-538.
19. Geinisman Y, Gundersen HJ, van der, Zee E, West MJ,. Unbiased stereological estimation of the total number of synapses in a brain region. J Neurocytol 1996; 25: 805-819.
20. Dosemeci A, Tao-Cheng JH, Vinade L, Winters CA, Pozzo-Miller L, Reese TS,. Glutamate-induced transient modification of the postsynaptic density. Proc Natl Acad Sci U S A 2001; 98: 10428-10432.
21. Terrando N, Rei Fidalgo A, Vizcaychipi M, Cibelli M, Ma D, Monaco C, Feldmann M, Maze M,. The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit Care 2010; 14: R88.
22. Small GW, Siddarth P, Silverman DH, Ercoli LM, Miller KJ, Lavretsky H, Bookheimer SY, Huang SC, Barrio JR, Phelps ME,. Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. Am J Geriatr Psychiatry 2008; 16: 999-1009.
23. Liang X, Wu L, Wang Q, Hand T, Bilak M, McCullough L, Andreasson K,. Function of COX-2 and prostaglandins in neurological disease. J Mol Neurosci 2007; 33: 94-99.
24. Andrade C, Singh NM, Thyagarajan S, Nagaraja N, Sanjay Kumar Rao N, Suresh Chandra J,. Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: experimental evidence for involvement of COX-2, and review of literature. J Psychiatr Res 2008; 42: 837-850.
25. Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA,. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 2000; 293: 417-425.
26. Siekevitz P,. The postsynaptic density: a possible role in long-lasting effects in the central nervous system. Proc Natl Acad Sci U S A 1985; 82: 3494-3498.
27. Sheng M, Hoogenraad CC,. The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu Rev Biochem 2007; 76: 823-847.
28. Kasai H, Matsuzaki M, Noguchi J, Yasumatsu N, Nakahara H,. Structure-stability-function relationships of dendritic spines. Trends Neurosci 2003; 26: 360-368.
29. Nicholson DA, Yoshida R, Berry RW, Gallagher M, Geinisman Y,. Reduction in size of perforated postsynaptic densities in hippocampal axospinous synapses and age-related spatial learning impairments. J Neurosci 2004; 24: 7648-7653.
30. Lunardi N, Ori C, Erisir A, Jevtovic-Todorovic V,. General anesthesia causes long-lasting disturbances in the ultrastructural properties of developing synapses in young rats. Neurotox Res 2010; 17: 179-188.
31. Tao YX, Johns RA,. Neuronal PDZ domains: a promising new molecular target for inhaled anesthetics? Mol Interv 2004; 4: 215-221.
32. Fang M, Tao YX, He F, Zhang M, Levine CF, Mao P, Tao F, Chou CL, Sadegh-Nasseri S, Johns RA,. Synaptic PDZ domain-mediated protein interactions are disrupted by inhalational anesthetics. J Biol Chem 2003; 278: 36669-36675.
33. Romsing J, Moiniche S,. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesthesiol Scand 2004; 48: 525-546.
34. Mehta V, Johnston A, Cheung R, Bello A, Langford RM,. Intravenous parecoxib rapidly leads to COX-2 inhibitory concentration of valdecoxib in the central nervous system. Clin Pharmacol Ther 2008; 83: 430-435.